References
- Keane W.F. Lipids and the kidney. Kidney Int. 1994; 46: 910–920
- Fernandez-Miranda C., de la Calle A., Morales J.M., Guijarro C., Aranda J.L., Gomez-Sanz R., Gomez-Izquierdo T., Larumbe S., Moreno E., Rodicio J.L., del Palacio A. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A Comparative study. Clin. Transplant 1998; 12: 136–141
- Kendrick E. Cardiovascular disease and the renal transplant recipient. Am. J. Kidney Dis. 2001; 38(6)S36–S43, Suppl 6
- Satterth-Waite R., Aswad S., Sunga V., Shidban H., Bogaard T., Asai P., Khetan U., Akra I., Mendez R.G., Mendez R. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. Transplantation 2000; 55: 446–449
- Land W. Future challenges in immunosuppression. Transplant Proc. 1998; 30: 1580–1584
- Bumgardner G.L., Wilson G.A., Tso P.L., Henry M.L., Elkhammas E.A., Davies E.A., Qiu W., Ferguson R.M. Impact of serum lipids on long-term graft and patient survival after renal transplantation. Transplantation 1995; 60: 1418–1421
- Aakhus S., Dahl K., Wideroe T.E. Hyperlipidemia in renal transplant patients. J. Int. Med. 1996; 239: 407–415
- Massy Z.A., Kasiske B.L. Post-transplant hyperlipidemia: Mechanism and management. J. Am. Soc. Nephrol. 1996; 7: 971–977
- Hanefeld M., Fischer S., Julius U., Schulze J., Schwanebeck U., Schnechel H., Ziegelasch H.J., Lindner J. Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-year follow-up. Diabetologia 1996; 39: 1577–1583
- Kasiske B. Long-term posttransplantation management and complications. Handbook of Kidney Transplantation, 3rd Ed., G.M. Danovitch. Williams and Wilkins, Philadelphia, PA, Lippincott 2001; 182–220
- Keane W.F. The role of lipids in renal disease: future challenges. Kidney Int. 2000; 57(Suppl 75)S27–S31
- Kasiske B.L., Umen A.J. Persistent hyperlipidemia in renal transplant patients. Medicine 1987; 66(4)309–315
- Cohan D., Galbraith C. General health management and long-term care of the renal transplant recipient. Am. J. Kidney Dis. 2001; 38(6 Suppl 6)S10–S24
- Wissing K.M., Abramowicz D., Broeders N., Vereer-straeten P. Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection. Transplantation 2000; 70: 464–472
- Gokal R., Mann J.I., Moore R.A., Morris P.J. Hyperlipidemia following renal transplantation. A study of the prevalence and “natural history” and dietary treatment. Q. J. Med. 1979; 48: 507–517
- Shen S.Y., Lukens C.W., Alongi S.V., Sfeir R.E., Dagher F.J., Sadler J.H. Patient profile and effect of dietary therapy on posttransplant hyperlipidemia. Kidney Int. Suppl. 1983; 16: S147–S152
- Moore R.A., Callahan M.F., Cody M., Adams P.L., Litchford M., Buckner K., Galloway J.L. The effect of the American Heart Association step one diet on hyperlipidemia following renal transplantation. Transplantation 1990; 49: 60–62
- Maltz H.C., Balog D.L., Cheigh J.S. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine. Ann. Pharmacother. 1999; 33: 1176–1179
- Abtahi P., Zand M.S. Management of hyperlipidemia in the stable solid organ transplant recipient. Graft 2001; 4: 266–273